v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Jun. 27, 2026
Jun. 28, 2025
OPERATING ACTIVITIES    
Net income $ 225.8 $ 297.1
Adjustments to reconcile net income to net cash provided by operating activities:    
Impairment, restructuring and other 15.7 16.0
Share-based compensation expense 38.3 55.6
Depreciation 47.0 47.1
Amortization 4.2 9.4
Deferred taxes 115.3 76.5
Loss on sale of business 101.8 0.0
Unrealized loss on investments 15.7 0.0
Equity in income of unconsolidated affiliates (11.6) (9.5)
Changes in assets and liabilities, net of acquisitions and dispositions:    
Accounts receivable (552.1) (395.2)
Inventories 61.1 42.5
Prepaid and other current assets (2.6) 12.6
Accounts payable 83.7 14.7
Other current liabilities 39.6 38.7
Other non-current items 20.0 (6.1)
Other, net (6.7) (2.2)
Net cash provided by operating activities 195.2 197.2
INVESTING ACTIVITIES    
Investments in property, plant and equipment (63.1) (54.5)
Net cash disposed of on sale of business (35.0) 0.0
Other investing, net (4.0) (5.5)
Net cash used in investing activities (102.1) (60.0)
FINANCING ACTIVITIES    
Borrowings under revolving and bank lines of credit and term loans 1,243.5 695.6
Repayments under revolving and bank lines of credit and term loans (1,237.8) (734.9)
Financing and issuance fees (8.9) 0.0
Dividends paid (116.3) (116.2)
Purchase of Common Shares (12.1) (18.4)
Cash received from exercise of stock options 3.9 11.2
Other financing, net 25.9 4.5
Net cash used in financing activities (101.8) (158.2)
Effect of exchange rate changes on cash (0.2) 0.5
Net decrease in cash and cash equivalents, including cash and cash equivalents classified within current assets held for sale (8.9) (20.5)
Less: Net increase (decrease) in cash and cash equivalents classified within current assets held for sale (3.8) 2.3
Net decrease in cash and cash equivalents (5.1) (22.8)
Cash and cash equivalents at beginning of period 32.8 62.4
Cash and cash equivalents at end of period $ 27.7 $ 39.6